Regenerative Medical Technology (RMTG) Current Assets (2017 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Current Assets of $1.6 million for Q1 2026, up 8.02% year-over-year from $1.4 million in Q1 2025, and up 28.05% quarter-over-quarter from $1.2 million in Q4 2025.
Regenerative Medical Technology (RMTG) Current Assets (2017 - 2026) Analysis & Trends
Regenerative Medical Technology's Current Assets history runs 10 years deep, the most recent figure standing at $1.6 million for Q1 2026.
- In Q1 2026, Current Assets rose 8.02% year-over-year to $1.6 million; the TTM figure through Mar 2026 stood at $1.6 million (up 8.02% YoY), while the FY2025 annual figure was $1.2 million, down 2.04% from the prior year.
- Current Assets for Q1 2026 stood at $1.6 million, up from $1.2 million in the prior quarter.
- The five-year high for Current Assets was $2.6 million in Q1 2022, with the low at $574996.0 in Q4 2023.
- The 5-year median for Current Assets is $1.4 million (2025), against an average of $1.4 million.
- Peak annual rise in Current Assets reached 235.49% in 2022, while the deepest fall reached 82.78% in 2022.
- Regenerative Medical Technology's Current Assets stood at $1.7 million in 2022, then plunged by 66.08% to $574996.0 in 2023, then soared by 117.08% to $1.2 million in 2024, then retreated by 2.04% to $1.2 million in 2025, then increased by 28.05% to $1.6 million in 2026.
- Business Quant data shows RMTG's Current Assets at $1.6 million in Q1 2026, $1.2 million in Q4 2025, and $1.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.61 Bn | 131.75 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.70 Bn | 78.71 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.28 Bn | 60.09 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 59.14 Bn | 54.00 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.13 Bn | 37.03 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.83 Bn | 28.52 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.07 Bn | 9.68 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.54 Bn | 26.38 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.76 Bn |
| 10 | Regenerative Medical Technology | 814,616.00 | -246,832.00 | 1.77 Mn | 1.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.57 Mn |
| Dec 31, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.51 Mn |
| Jun 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 1.45 Mn |
| Dec 31, 2024 | 1.25 Mn |
| Sep 30, 2024 | 917,180.00 |
| Jun 30, 2024 | 686,571.00 |
| Mar 31, 2024 | 668,358.00 |
| Dec 31, 2023 | 574,996.00 |
| Sep 30, 2023 | 1.19 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 1.74 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 1.86 Mn |
| Jun 30, 2022 | 1.95 Mn |
| Mar 31, 2022 | 2.64 Mn |
| Dec 31, 2021 | 3.02 Mn |
| Sep 30, 2021 | 10.77 Mn |
| Jun 30, 2021 | 10.74 Mn |